An Overview of the Potentialities of Antimicrobial Peptides Derived from Natural Sources

Antimicrobial peptides (AMPs) are constituents of the innate immune system in every kind of living organism. They can act by disrupting the microbial membrane or without affecting membrane stability. Interest in these small peptides stems from the fear of antibiotics and the emergence of microorgani...

Full description

Saved in:
Bibliographic Details
Main Authors: Irene Dini (Author), Margherita-Gabriella De Biasi (Author), Andrea Mancusi (Author)
Format: Book
Published: MDPI AG, 2022-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b185e7051f9f44e39d3500a0cfe6a747
042 |a dc 
100 1 0 |a Irene Dini  |e author 
700 1 0 |a Margherita-Gabriella De Biasi  |e author 
700 1 0 |a Andrea Mancusi  |e author 
245 0 0 |a An Overview of the Potentialities of Antimicrobial Peptides Derived from Natural Sources 
260 |b MDPI AG,   |c 2022-10-01T00:00:00Z. 
500 |a 10.3390/antibiotics11111483 
500 |a 2079-6382 
520 |a Antimicrobial peptides (AMPs) are constituents of the innate immune system in every kind of living organism. They can act by disrupting the microbial membrane or without affecting membrane stability. Interest in these small peptides stems from the fear of antibiotics and the emergence of microorganisms resistant to antibiotics. Through membrane or metabolic disruption, they defend an organism against invading bacteria, viruses, protozoa, and fungi. High efficacy and specificity, low drug interaction and toxicity, thermostability, solubility in water, and biological diversity suggest their applications in food, medicine, agriculture, animal husbandry, and aquaculture. Nanocarriers can be used to protect, deliver, and improve their bioavailability effectiveness. High cost of production could limit their use. This review summarizes the natural sources, structures, modes of action, and applications of microbial peptides in the food and pharmaceutical industries. Any restrictions on AMPs' large-scale production are also taken into consideration. 
546 |a EN 
690 |a AMPs 
690 |a food preservation 
690 |a food shelf-life 
690 |a active packaging 
690 |a Gram-positive bacteria 
690 |a Gram-negative bacteria 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 11, Iss 11, p 1483 (2022) 
787 0 |n https://www.mdpi.com/2079-6382/11/11/1483 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/b185e7051f9f44e39d3500a0cfe6a747  |z Connect to this object online.